Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

596
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
596
Air-entraining Agents01:27

Air-entraining Agents

293
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
293
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.7K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.7K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

700
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
700
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

1.2K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>ag85A</i> loss promotes free mycolate accumulation and sensitizes plasma membrane domain to disruption.

Journal of bacteriology·2026
Same author

Identification of chemical features for improved outer membrane permeation in mycobacteria using machine learning.

Nature microbiology·2026
Same author

Loss of essential outer membrane functions causes drug hypersensitization in <i>Acinetobacter baumannii</i> overexpressing multidrug efflux pumps.

mBio·2026
Same author

Rifamycin Structural Modifications Attenuate PXR Binding and CYP3A4 Induction.

Journal of medicinal chemistry·2026
Same author

Cytochrome P450-Mediated Metabolism of Antimycobacterial <i>N</i>α-Aroyl-<i>N</i>-aryl-phenylalanine Amides.

ACS infectious diseases·2026
Same author

Social Science Strengthens One Health: A Participatory Approach to Codevelop a Guidebook on Countering Zoonotic Spillover in Southeast Asia, 2022-2024.

Health security·2026

Related Experiment Video

Updated: Feb 16, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.6K

Novel Pyrimidines as Antitubercular Agents.

Daigo Inoyama1,2, Steven D Paget1,2, Riccardo Russo3,2

  • 1Department of Pharmacology, Physiology and Neuroscience, Rutgers University, New Jersey Medical School, Newark, New Jersey, USA.

Antimicrobial Agents and Chemotherapy
|January 10, 2018
PubMed
Summary

Researchers developed novel pyrimidine analogs to combat multidrug-resistant tuberculosis. These compounds show promising in vitro activity and favorable pharmacokinetic profiles, offering a new avenue for tuberculosis drug discovery.

Keywords:
Mycobacterium tuberculosisantitubercularpharmacokineticspyrimidine

More Related Videos

Application of a Coupling Agent to Improve the Dielectric Properties of Polymer-Based Nanocomposites
06:34

Application of a Coupling Agent to Improve the Dielectric Properties of Polymer-Based Nanocomposites

Published on: September 19, 2020

6.4K
Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
12:17

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.

Published on: March 17, 2008

16.0K

Related Experiment Videos

Last Updated: Feb 16, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.6K
Application of a Coupling Agent to Improve the Dielectric Properties of Polymer-Based Nanocomposites
06:34

Application of a Coupling Agent to Improve the Dielectric Properties of Polymer-Based Nanocomposites

Published on: September 19, 2020

6.4K
Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
12:17

Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.

Published on: March 17, 2008

16.0K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Microbiology

Background:

  • Tuberculosis (TB) remains a global health crisis, demanding new drugs.
  • Existing treatments face challenges with cross-resistance from Mycobacterium tuberculosis.
  • Novel chemical scaffolds are crucial for developing next-generation antitubercular therapies.

Purpose of the Study:

  • To design and synthesize novel pyrimidine analogs.
  • To evaluate the in vitro activity, cytotoxicity, and ADME properties of these compounds.
  • To assess the pharmacokinetic profiles of promising candidates in vivo.

Main Methods:

  • Structure-activity relationship (SAR) studies based on a triazine lead.
  • Chemical synthesis of a focused pyrimidine analog library.
  • In vitro assays for antimycobacterial activity and cytotoxicity.
  • Physiochemical and ADME profiling.
  • Pharmacokinetic studies in murine models.

Main Results:

  • Successful synthesis of a diverse pyrimidine analog series.
  • Identification of compounds with potent in vitro antimycobacterial activity.
  • Favorable ADME and physiochemical properties observed in select analogs.
  • Promising pharmacokinetic profiles demonstrated in mice for lead compounds.

Conclusions:

  • The pyrimidine series represents a promising scaffold for antitubercular drug development.
  • These compounds may share activation mechanisms with clinical drug PA-824.
  • Findings provide guidelines for optimizing small-molecule antitubercular agents.
  • Further evolution of this chemical series is warranted.